United Therapeutics Corp’s recent filing unveils that its CFO AND TREASURER EDGEMOND JAMES unloaded Company’s shares for reported $3.91 million on Jun 02 ’25. In the deal valued at $325.82 per share,12,000 shares were sold. As a result of this transaction, EDGEMOND JAMES now holds 8,118 shares worth roughly $2.67 million.
Then, JAMES EDGEMOND bought 111,500 shares, generating $35,551,775 in total proceeds.
Before that, MAHON PAUL A sold 11,000 shares. United Therapeutics Corp shares valued at $3,476,765 were divested by the EVP & GENERAL COUNSEL at a price of $316.07 per share. As a result of the transaction, MAHON PAUL A now holds 36,781 shares, worth roughly $12.08 million.
Cantor Fitzgerald initiated its United Therapeutics Corp [UTHR] rating to an Overweight in a research note published on June 02, 2025; the price target was $405. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who decreased its forecast for the stock in late April from “an Overweight” to “an Equal weight”. BofA Securities also remained covering UTHR and has increased its forecast on April 21, 2025 with a “Neutral” recommendation from previously “an Underperform” rating. Morgan Stanley revised its rating on July 11, 2024. It rated UTHR as “an Equal-weight” which previously was an “an Overweight”.
Price Performance Review of UTHR
On Monday, United Therapeutics Corp [NASDAQ:UTHR] saw its stock jump 0.79% to $328.40. Over the last five days, the stock has gained 0.90%. United Therapeutics Corp shares have fallen nearly -6.93% since the year began. Nevertheless, the stocks have risen 18.67% over the past one year. While a 52-week high of $417.82 was reached on 02/19/25, a 52-week low of $266.98 was recorded on 04/09/25. SMA at 50 days reached $302.83, while 200 days put it at $342.21.
Levels Of Support And Resistance For UTHR Stock
The 24-hour chart illustrates a support level at 324.67, which if violated will result in even more drops to 320.94. On the upside, there is a resistance level at 330.99. A further resistance level may holdings at 333.58. The Relative Strength Index (RSI) on the 14-day chart is 65.99, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 6.58, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 20.49%. Stochastics %K at 69.54% indicates the stock is a holding.
